Zhongyuan Union Cell & Gene Eng
Zhongyuan Union Cell & Gene Eng is principally engaged in the detection and storage of stem cell sources.
Launch date
Employees
Market cap
CAD1.6b
Enterprise valuation
CAD1.4b (Public information from Sep 2024)
Share price
CNY17.91 600645.SS
Tianjin Tianjin Shi (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.3b | 1.5b | 1.6b | 1.6b | 1.7b | 1.9b | 2.0b |
| % growth | (5 %) | 16 % | 1 % | 2 % | 9 % | 7 % | 8 % |
| EBITDA | 279m | 414m | 313m | 305m | 347m | 387m | 433m |
| % EBITDA margin | 21 % | 27 % | 20 % | 19 % | 20 % | 21 % | 22 % |
| Profit | (127m) | 155m | 113m | 106m | 147m | 171m | 200m |
| % profit margin | (10 %) | 10 % | 7 % | 7 % | 8 % | 9 % | 10 % |
| EV / revenue | 7.0x | 7.0x | 4.3x | 5.0x | 4.4x | 4.1x | 3.8x |
| EV / EBITDA | 32.9x | 25.8x | 21.4x | 26.3x | 21.8x | 19.6x | 17.5x |
| R&D budget | 114m | 135m | 147m | 184m | - | - | - |
| R&D % of revenue | 9 % | 9 % | 9 % | 12 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Zhongyuan Union Cell & Gene Eng
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
